MEDICINE DETAILS
Tecvayli
Active ingredient: Teclistamab Cqyv
Neutral reference profile for an independent medicine-access consultancy enquiry about Tecvayli (Teclistamab Cqyv). No medicine is offered for sale.
NEXT STEP
Choose the strength and pack
✓ If you are unsure, choose “I do not know”.
These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.
ABOUT THIS MEDICINE
What is Tecvayli used for?
Tecvayli is a bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager indicated for the treatment of adult patients with relapsed or refractory multiple myeloma. The treatment is indicated for such patients who had received four or more previous lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. It is administered through under-the-skin injections.
This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.
RECORDED PRODUCT PROFILE
Tecvayli identity, dosage form and pack information.
The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.
Recorded strength and pack options
Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.
-
10 mg/ml (30 mg total) · 1 vial (3 ml) Catalogue organisation: JANSSEN-CILAG GmbH
-
90 mg/ml (153 mg total) · 1 vial (1.7 ml) Catalogue organisation: JANSSEN-CILAG GmbH
OFFICIAL SOURCES
Check the Tecvayli record at an official source.
Search for “Tecvayli” or “Teclistamab Cqyv”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.
OFFICIAL EXTERNAL SOURCE
European Medicines Agency (EMA)
Search medicines evaluated by EMA by brand name or active substance. EMA also links to national registers for nationally authorised products.
↗ OFFICIAL EXTERNAL SOURCE Drugs@FDASearch FDA-approved human drug records by brand name or active ingredient, including current labelling where available.
↗SERVICE BOUNDARY
Information checking and independent enquiry support for Tecvayli.
OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.
Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.
CLEAR ANSWERS
Frequently asked questions about Tecvayli
01What is Tecvayli?＋
This directory record associates the brand name Tecvayli with the active ingredient Teclistamab Cqyv. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.
02Which Tecvayli strengths and packs are recorded?＋
The catalogue currently shows: 10 mg/ml (30 mg total) · 1 vial (3 ml); 90 mg/ml (153 mg total) · 1 vial (1.7 ml). Check the complete strength, dosage form and pack description against the prescription and medicine box.
03Who manufactures Tecvayli?＋
Catalogue records currently name: JANSSEN-CILAG GmbH. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.
04Do the listed options confirm stock or access?＋
No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.
05What affects a possible estimated medicine cost for Tecvayli?＋
A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Tecvayli, payment request, stock guarantee or binding offer.
06Can I buy Tecvayli from this website?＋
No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.